Literature DB >> 16861745

Synaptic defects at meiosis I and non-obstructive azoospermia.

Daniel Topping1, Petrice Brown, LuAnn Judis, Stuart Schwartz, Allen Seftel, Anthony Thomas, Terry Hassold.   

Abstract

BACKGROUND: Recent advances in immunofluorescence methodology have made it possible to directly monitor protein localization patterns in germ cells undergoing meiosis. We used this technology to examine the early stages of meiosis in testicular material obtained from men presenting for evaluation at infertility clinics.
METHODS: Specifically, we compared meiotic progression, synapsis and recombination in 34 individuals with obstructive azoospermia ('controls') to 26 individuals with non-obstructive azoospermia (NOA) ('cases').
RESULTS: In 9 of the 26 cases, no germ cells were identified, but in the remaining 17, there was at least some progression through meiosis. Most of these individuals appeared to have normal levels of spermatogenic activity, with little evidence of meiotic impairment. However, in three individuals, we observed either complete or partial meiotic arrest associated with abnormalities in synapsis.
CONCLUSIONS: This suggests that >10% of cases of unexplained NOA may be attributable to severe meiotic defects. The characterization of these meiotic arrest phenotypes may guide further research into the molecular basis of unexplained infertility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861745     DOI: 10.1093/humrep/del281

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  Decreased XY recombination and disturbed meiotic prophase I progression in an infertile 48, XYY, +sSMC man.

Authors:  Liu Wang; Zhipeng Xu; Furhan Iqbal; Liangwen Zhong; Yuanwei Zhang; Caiyun Wu; Guixiang Zhou; Hanwei Jiang; Ihtisham Bukhari; Howard J Cooke; Qinghua Shi
Journal:  Chromosome Res       Date:  2015-01-28       Impact factor: 5.239

Review 2.  Meiotic recombination and male infertility: from basic science to clinical reality?

Authors:  Michael C Hann; Patricio E Lau; Helen G Tempest
Journal:  Asian J Androl       Date:  2011-02-07       Impact factor: 3.285

3.  On the origin of crossover interference: A chromosome oscillatory movement (COM) model.

Authors:  Maj A Hultén
Journal:  Mol Cytogenet       Date:  2011-04-08       Impact factor: 2.009

4.  Correlations between Synaptic Initiation and Meiotic Recombination: A Study of Humans and Mice.

Authors:  Jennifer R Gruhn; Nasser Al-Asmar; Rachael Fasnacht; Heather Maylor-Hagen; Vanessa Peinado; Carmen Rubio; Karl W Broman; Patricia A Hunt; Terry Hassold
Journal:  Am J Hum Genet       Date:  2015-12-31       Impact factor: 11.025

Review 5.  Cytogenetic determinants of male fertility.

Authors:  R H Martin
Journal:  Hum Reprod Update       Date:  2008-06-04       Impact factor: 15.610

6.  Reduced meiotic recombination on the XY bivalent is correlated with an increased incidence of sex chromosome aneuploidy in men with non-obstructive azoospermia.

Authors:  F Sun; M Mikhaail-Philips; M Oliver-Bonet; E Ko; A Rademaker; P Turek; R H Martin
Journal:  Mol Hum Reprod       Date:  2008-06-26       Impact factor: 4.025

7.  Translation of the synaptonemal complex component Sycp3 is enhanced in vivo by the germ cell specific regulator Dazl.

Authors:  Nicola Reynolds; Brian Collier; Victoria Bingham; Nicola K Gray; Howard J Cooke
Journal:  RNA       Date:  2007-05-25       Impact factor: 4.942

8.  Cytological studies of human meiosis: sex-specific differences in recombination originate at, or prior to, establishment of double-strand breaks.

Authors:  Jennifer R Gruhn; Carmen Rubio; Karl W Broman; Patricia A Hunt; Terry Hassold
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

9.  ALDH Enzyme Expression Is Independent of the Spermatogenic Cycle, and Their Inhibition Causes Misregulation of Murine Spermatogenic Processes.

Authors:  Travis Kent; Samuel L Arnold; Rachael Fasnacht; Ross Rowsey; Debra Mitchell; Cathryn A Hogarth; Nina Isoherranen; Michael D Griswold
Journal:  Biol Reprod       Date:  2015-12-02       Impact factor: 4.285

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.